Is azithromycin (Zithromax) appropriate for intrapartum prophylaxis of Group B Streptococcus (Streptococcus agalactiae)?

Azithromycin (Zithromax) is NOT recommended for Group B Streptococcus intrapartum prophylaxis

Azithromycin is not included in the CDC guidelines for GBS prophylaxis and should not be used for this indication. The CDC 2010 guidelines provide a clear algorithm for antibiotic selection that does not include azithromycin at any point 1.

Recommended Antibiotic Algorithm for GBS Prophylaxis

For Non-Penicillin Allergic Patients:

• First-line: Penicillin G (5 million units IV initial, then 2.5-3.0 million units every 4 hours) OR Ampicillin (2g IV initial, then 1g every 4 hours) 1

For Penicillin-Allergic Patients WITHOUT High-Risk Features:

• Use Cefazolin: 2g IV initial dose, then 1g every 8 hours 1
• High-risk features = history of anaphylaxis, angioedema, respiratory distress, or urticaria to penicillin/cephalosporins

For Penicillin-Allergic Patients WITH High-Risk Features:

The choice depends on susceptibility testing 1:

• If GBS isolate is susceptible to BOTH clindamycin AND erythromycin: Use Clindamycin 900mg IV every 8 hours
• If susceptibility unknown OR resistant to either: Use Vancomycin 1g IV every 12 hours

Why Azithromycin is Not Appropriate

1. Not FDA-approved for GBS prophylaxis: The FDA label for Zithromax lists only community-acquired pneumonia and pelvic inflammatory disease as IV indications—GBS prophylaxis is absent 2

2. High resistance rates: Recent surveillance shows erythromycin (macrolide class, same as azithromycin) resistance in GBS reaches 26.1% in some populations 3. The M phenotype with mef(A) gene predominates, conferring macrolide resistance 3

3. Guideline exclusion is deliberate: The 2020 AAP guidelines explicitly state "Erythromycin is not recommended because GBS is increasingly resistant to macrolide antibiotics" 4. Azithromycin, being a macrolide, falls under this same exclusion

4. No evidence of efficacy: Recent research shows azithromycin provides no benefit in reducing perinatal infections in labor induction settings 5

Critical Clinical Pitfall

Do not substitute azithromycin for clindamycin in penicillin-allergic patients. While both are alternatives to beta-lactams, only clindamycin (when susceptibility is confirmed) is guideline-recommended 1. Using azithromycin could result in inadequate prophylaxis and increased risk of neonatal early-onset GBS disease, which carries significant morbidity and mortality 6.

When Susceptibility Testing is Unavailable

If a penicillin-allergic patient at high risk for anaphylaxis presents in labor without susceptibility results, use vancomycin as the default 1. This ensures adequate coverage given the high rates of clindamycin/erythromycin resistance and the critical importance of preventing neonatal sepsis.